JAMA Internal Medicine最新文献

筛选
英文 中文
Areas to Refine in the Skills to Manage Pain (STOMP) Trial. 疼痛管理技能(STOMP)试验中有待完善的领域。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5620
Yuqing Gui, Lihua Chen, Zining Luo
{"title":"Areas to Refine in the Skills to Manage Pain (STOMP) Trial.","authors":"Yuqing Gui, Lihua Chen, Zining Luo","doi":"10.1001/jamainternmed.2024.5620","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.5620","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Areas to Refine in the Skills to Manage Pain (STOMP) Trial. 疼痛管理技能(STOMP)试验中有待完善的领域。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5623
Desmond Y H Yap, Kwok Ying Chan, Man Lui Chan
{"title":"Areas to Refine in the Skills to Manage Pain (STOMP) Trial.","authors":"Desmond Y H Yap, Kwok Ying Chan, Man Lui Chan","doi":"10.1001/jamainternmed.2024.5623","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.5623","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the Multitarget Stool DNA Test Just a Better "FIT" for Colorectal Cancer Screening? 多靶点粪便 DNA 检测仪只是更好的大肠癌筛查 "FIT "吗?
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.6152
Thomas F Imperiale
{"title":"Is the Multitarget Stool DNA Test Just a Better \"FIT\" for Colorectal Cancer Screening?","authors":"Thomas F Imperiale","doi":"10.1001/jamainternmed.2024.6152","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.6152","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Areas to Refine in the Skills to Manage Pain (STOMP) Trial. 疼痛管理技能(STOMP)试验中有待完善的领域。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5617
Bingdian Wang, Deqin Li, Xueqi Liu
{"title":"Areas to Refine in the Skills to Manage Pain (STOMP) Trial.","authors":"Bingdian Wang, Deqin Li, Xueqi Liu","doi":"10.1001/jamainternmed.2024.5617","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.5617","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening. 下一代多靶点粪便 DNA 与粪便免疫化学检验在结肠直肠癌筛查中的对比。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.6149
Teresa Seum, Tobias Niedermaier, Thomas Heisser, Michael Hoffmeister, Hermann Brenner
{"title":"Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening.","authors":"Teresa Seum, Tobias Niedermaier, Thomas Heisser, Michael Hoffmeister, Hermann Brenner","doi":"10.1001/jamainternmed.2024.6149","DOIUrl":"10.1001/jamainternmed.2024.6149","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing National Standards for Carceral Health Care-The Federal Prison Oversight Act. 建立国家监狱卫生保健标准--联邦监狱监督法案》。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.6155
Lawrence A Haber, Chesa Boudin, Brie A Williams
{"title":"Establishing National Standards for Carceral Health Care-The Federal Prison Oversight Act.","authors":"Lawrence A Haber, Chesa Boudin, Brie A Williams","doi":"10.1001/jamainternmed.2024.6155","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.6155","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Over-the-Counter Medication Abortion as a Strategy to Expand Access to Care. 将非处方药流产作为扩大医疗服务的一项战略。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.6325
Daniel Grossman, Emma Chew Murphy
{"title":"Over-the-Counter Medication Abortion as a Strategy to Expand Access to Care.","authors":"Daniel Grossman, Emma Chew Murphy","doi":"10.1001/jamainternmed.2024.6325","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.6325","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis. 严重低钠血症住院成人的纠正率和临床结果:系统综述与元分析》。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5981
Juan Carlos Ayus, Michael L Moritz, Nora Angélica Fuentes, Jhonatan R Mejia, Juan Martín Alfonso, Saeha Shin, Michael Fralick, Agustín Ciapponi
{"title":"Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis.","authors":"Juan Carlos Ayus, Michael L Moritz, Nora Angélica Fuentes, Jhonatan R Mejia, Juan Martín Alfonso, Saeha Shin, Michael Fralick, Agustín Ciapponi","doi":"10.1001/jamainternmed.2024.5981","DOIUrl":"10.1001/jamainternmed.2024.5981","url":null,"abstract":"<p><strong>Importance: </strong>Hyponatremia treatment guidelines recommend limiting the correction of severe hyponatremia during the first 24 hours to prevent osmotic demyelination syndrome (ODS). Recent evidence suggests that slower rates of correction are associated with increased mortality.</p><p><strong>Objective: </strong>To evaluate the association of sodium correction rates with mortality among hospitalized adults with severe hyponatremia.</p><p><strong>Data sources: </strong>We searched MEDLINE, Embase, the Cochrane Library, LILACS, Web of Science, CINAHL, and international congress proceedings for studies published between January 2013 and October 2023.</p><p><strong>Study selection: </strong>Comparative studies assessing rapid (≥8-10 mEq/L per 24 hours) vs slow (<8 or 6-10 mEq/L per 24 hours) and very slow (<4-6 mEq/L per 24 hours) correction of severe hyponatremia (serum sodium <120 mEq/L or <125 mEq/L plus severe symptoms) in hospitalized patients.</p><p><strong>Data extraction and synthesis: </strong>Pairs of reviewers (N.A.F., J.R.M., J.M.A., A.C.) independently reviewed studies, extracted data, and assessed each included study's risk of bias using ROBINS-I. Cochrane methods, PRISMA reporting guidelines, and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to rate the certainty of evidence were followed. Data were pooled using a random-effects model.</p><p><strong>Main outcomes and measures: </strong>Primary outcomes were in-hospital and 30-day mortality, and secondary outcomes were hospital length of stay (LOS) and ODS.</p><p><strong>Results: </strong>Sixteen cohort studies involving a total of 11 811 patients with severe hyponatremia were included (mean [SD] age, 68.22 [6.88] years; 56.7% female across 15 studies reporting sex). Moderate-certainty evidence showed that rapid correction was associated with 32 (odds ratio, 0.67; 95% CI, 0.55-0.82) and 221 (odds ratio, 0.29; 95% CI, 0.11-0.79) fewer in-hospital deaths per 1000 treated patients compared with slow and very slow correction, respectively. Low-certainty evidence suggested that rapid correction was associated with 61 (risk ratio, 0.55; 95% CI, 0.45-0.67) and 134 (risk ratio, 0.35; 95% CI, 0.28-0.44) fewer deaths per 1000 treated patients at 30 days and with a reduction in LOS of 1.20 (95% CI, 0.51-1.89) and 3.09 (95% CI, 1.21-4.94) days, compared with slow and very slow correction, respectively. Rapid correction was not associated with a statistically significant increased risk of ODS.</p><p><strong>Conclusions and relevance: </strong>In this systematic review and meta-analysis, slow correction and very slow correction of severe hyponatremia were associated with an increased risk of mortality and hospital LOS compared to rapid correction.</p>","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Borrowing From the Type 2 Diabetes Armamentarium for Asthma. 借鉴 2 型糖尿病的治疗方法来治疗哮喘。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5983
Katherine N Cahill, Dinah Foer
{"title":"Borrowing From the Type 2 Diabetes Armamentarium for Asthma.","authors":"Katherine N Cahill, Dinah Foer","doi":"10.1001/jamainternmed.2024.5983","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.5983","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antidiabetic Medication and Asthma Attacks. 抗糖尿病药物与哮喘发作
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-18 DOI: 10.1001/jamainternmed.2024.5982
Bohee Lee, Kenneth K C Man, Ernie Wong, Tricia Tan, Aziz Sheikh, Chloe I Bloom
{"title":"Antidiabetic Medication and Asthma Attacks.","authors":"Bohee Lee, Kenneth K C Man, Ernie Wong, Tricia Tan, Aziz Sheikh, Chloe I Bloom","doi":"10.1001/jamainternmed.2024.5982","DOIUrl":"10.1001/jamainternmed.2024.5982","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Elevated body mass index (BMI) and type 2 diabetes are prevalent in asthma and are associated with an increase in the risk of asthma attacks. In experimental studies, the diabetes medications metformin and glucagon-like peptide-1 receptor agonists (GLP-1RA) have mitigated airway inflammation, hyperresponsiveness, and remodeling. However, epidemiological evidence is limited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To estimate the association of metformin and add-on antidiabetic medications (GLP-1RA, dipeptidyl peptidase-4 inhibitors, sulphonylureas, sodium-glucose cotransporter-2 inhibitors, and insulin) with asthma attacks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;The study used data from the UK Clinical Practice Research Datalink (CPRD) Aurum linked hospital admissions and mortality data from 2004 to 2020. A triangulation approach was used that applied 2 distinct approaches to enhance robustness: a self-controlled case series (SCCS) and a metformin new user cohort with inverse probability of treatment weighting (IPTW). Eligible participants were new users of metformin with type 2 diabetes. To evaluate the association between metabolic phenotypes (BMI, glycemic control) and asthma phenotypes (type 2 inflammation, asthma severity), interaction analyses were conducted. Negative control analyses were conducted to assess for bias.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposure: &lt;/strong&gt;The primary exposure was metformin; secondary exposures included add-on antidiabetic medications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes: &lt;/strong&gt;The primary outcome was first asthma exacerbation (short course of oral corticosteroids, unscheduled asthma-related hospital attendance, or death) during 12-month follow-up. Incidence rate ratios (IRRs) with 95% CIs were estimated using fixed-effect conditional Poisson models in the SCCS, and hazard ratios (HRs) were estimated using weighted Cox proportional hazards models in the cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of more than 2 million adults with asthma, 4278 patients (2617 women [61.2%]; mean [SD] age, 52.9 [13.6] years) were identified for the SCCS and 8424 patients (4690 women [55.7%]; unexposed: mean [SD] age, 61.6 [13.2] years; exposed: mean [SD] age, 59.7 [13.7] years) for the IPTW cohort. Metformin was found to be associated with fewer asthma attacks of similar magnitude in both approaches (SCCS: IRR, 0.68; 95% CI, 0.62-0.75; IPTW: HR, 0.76; 95% CI, 0.67-0.85). Negative control analyses did not find evidence of significant bias. Hemoglobin A1c levels, BMI, blood eosinophil cell counts, and asthma severity did not modify the association. The only add-on antidiabetic medication to have an additive association was GLP-1RA (SCCS: IRR, 0.60; 95% CI, 0.49-0.73).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;The results of this cohort study suggest that metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. This appeared to be associated with mechani","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信